Innova Captab Limited (INNOVACAP.NS)
INR 875.7
(5.21%)
INR 875.7
(5.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.53 Billion INR | 35.09% |
| 2022 | 1.11 Billion INR | 22.62% |
| 2021 | 911.48 Million INR | 82.4% |
| 2020 | 499.72 Million INR | -26.05% |
| 2019 | 675.72 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 394.46 Million INR | -7.52% |
| 2023 Q2 | 356.53 Million INR | 18.06% |
| 2023 Q3 | 420.05 Million INR | 17.82% |
| 2023 Q1 | 301.99 Million INR | -67.27% |
| 2023 FY | 1.5 Billion INR | 35.09% |
| 2023 Q4 | 403.58 Million INR | -3.92% |
| 2022 Q3 | 341.76 Million INR | 0.0% |
| 2022 FY | 1.11 Billion INR | 22.62% |
| 2022 Q4 | 922.71 Million INR | 169.99% |
| 2021 FY | 911.48 Million INR | 82.4% |
| 2020 FY | 499.72 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 56.003% |
| Hester Biosciences Limited | 364.77 Million INR | -594.523% |
| Aarti Drugs Limited | 7.14 Billion INR | 64.561% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 19.012% |
| Albert David Limited | 1.33 Billion INR | -89.846% |
| Alembic Limited | 767.77 Million INR | -229.97% |
| Alkem Laboratories Limited | 19.46 Billion INR | 86.983% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -965.976% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -12164.766% |
| Brooks Laboratories Limited | -72.25 Million INR | 3606.353% |
| Eris Lifesciences Limited | 5.18 Billion INR | 51.109% |
| FDC Limited | 3.03 Billion INR | 16.492% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 71.786% |
| Gufic Biosciences Limited | 2.89 Billion INR | 12.454% |
| Hikal Limited | 1.49 Billion INR | -69.55% |
| Ind-Swift Limited | 1.22 Billion INR | -106.646% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 48.739% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -1083.615% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 51.177% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -32.895% |
| Lupin Limited | 27.75 Billion INR | 90.873% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -9126.491% |
| Medico Remedies Limited | 277.11 Million INR | -814.199% |
| Morepen Laboratories Limited | 4.17 Billion INR | 39.303% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 34.884% |
| Orchid Pharma Limited | 2.36 Billion INR | -7.299% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 9.066% |
| RPG Life Sciences Limited | 2.29 Billion INR | -10.518% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -1117.693% |
| Sigachi Industries Limited | 1.47 Billion INR | -71.885% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 165.753% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 45.017% |
| Themis Medicare Limited | 1.3 Billion INR | -94.413% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -40151.192% |
| Wanbury Limited | 1.7 Billion INR | -48.395% |
| Windlas Biotech Limited | 1.29 Billion INR | -95.044% |
| ZIM Laboratories Limited | 1.09 Billion INR | -130.706% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -26.101% |
| Ipca Laboratories Limited | 29.59 Billion INR | 91.44% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 97.571% |
| Venus Remedies Limited | 534.65 Million INR | -373.844% |
| Sakar Healthcare Limited | 495.5 Million INR | -411.277% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 97.576% |
| Divi's Laboratories Limited | 18.31 Billion INR | 86.164% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 43.374% |
| Mankind Pharma Limited | 40.86 Billion INR | 93.801% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | 35.84% |
| Neuland Laboratories Limited | 5.31 Billion INR | 52.362% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 66.408% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 61.039% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 94.419% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -307.939% |
| Wockhardt Limited | 140 Million INR | -1709.579% |
| Bal Pharma Limited | 214.56 Million INR | -1080.697% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 96.259% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -105.801% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -359.293% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 64.937% |
| Shilpa Medicare Limited | 3.76 Billion INR | 32.65% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 87.125% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -89393.667% |
| Granules India Limited | 6.52 Billion INR | 61.193% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -916.409% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 90.0% |
| NATCO Pharma Limited | 25.96 Billion INR | 90.242% |
| Suven Life Sciences Limited | -1.22 Billion INR | 306.67% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 51.521% |
| Indoco Remedies Limited | 1.52 Billion INR | -66.191% |
| Alpa Laboratories Limited | 61.51 Million INR | -4018.361% |
| Lasa Supergenerics Limited | -458 Million INR | 653.14% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 161.565% |